ALTUVIIIO
Biological
GENZYME CORPORATION
Total Payments
$1.9M
Transactions
1,943
Doctors
507
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.2M | 1,099 | 351 |
| 2023 | $712,711 | 844 | 266 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.4M | 466 | 75.7% |
| Travel and Lodging | $228,438 | 518 | 12.1% |
| Consulting Fee | $142,079 | 17 | 7.5% |
| Food and Beverage | $68,860 | 936 | 3.6% |
| Unspecified | $20,000 | 2 | 1.1% |
| Education | $38.75 | 4 | 0.0% |
Payments by Type
General
$1.9M
1,941 transactions
Research
$20,000
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Real-world Experience of Efanesoctocog Alfa Prophylaxis in US Patients with Hemophilia A | SANOFI US SERVICES INC. | $20,000 | 0 |
Top Doctors Receiving Payments for ALTUVIIIO — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , APRN | Pediatrics | Hartford, CT | $19,337 | 20 |
| , NP-C | Pediatrics | Sacramento, CA | $18,024 | 26 |
| , MD | Hematology & Oncology | San Diego, CA | $17,133 | 3 |
| , MD | Pediatric Hematology-Oncology | New Orleans, LA | $17,128 | 14 |
| , M.D | Internal Medicine | Memphis, TN | $17,103 | 15 |
| , MD | Pediatrics | Washington, DC | $14,258 | 6 |
| , MD | Pediatrics | Detroit, MI | $10,314 | 7 |
| , M.D | Pediatric Hematology-Oncology | Baton Rouge, LA | $9,738 | 11 |
| , APRN | Family | Louisville, KY | $9,648 | 19 |
| , MBBS | Hematology & Oncology | San Antonio, TX | $9,258 | 6 |
| , ARNP | Registered Nurse | Miami, FL | $8,691 | 17 |
| Andrew Wurster | Family | Buffalo, NY | $8,653 | 13 |
| , MD | Pediatric Hematology-Oncology | Charleston, SC | $8,466 | 8 |
| , MD | Pediatrics | Philadelphia, PA | $8,404 | 5 |
| , D.O | Pediatric Hematology-Oncology | Cleveland, OH | $8,233 | 7 |
| , M.D | Pediatrics | Syracuse, NY | $8,208 | 5 |
| , D.O | Pediatrics | Madison, WI | $7,752 | 5 |
| , DO | Pediatric Hematology-Oncology | Las Vegas, NV | $7,682 | 6 |
| , MBBS | Pediatric Hematology-Oncology | Omaha, NE | $7,086 | 4 |
| , DO | Pediatrics | Columbia, SC | $7,017 | 7 |
| , MD | Pediatrics | Charlotte, NC | $6,989 | 10 |
| , RN, APRN, PPNP-BC | Pediatric Oncology | Washington, DC | $6,733 | 10 |
| , M.D | Pediatrics | Kamuela, HI | $6,682 | 5 |
| , PA-C, DMSC, MPAS | Physician Assistant | Charlotte, NC | $6,198 | 10 |
| , APRN | Nurse Practitioner | Kansas City, MO | $4,717 | 7 |
Ad
Manufacturing Companies
- GENZYME CORPORATION $1.9M
- SANOFI US SERVICES INC. $20,000
- SWEDISH ORPHAN BIOVITRUM AB $17,133
Product Information
- Type Biological
- Total Payments $1.9M
- Total Doctors 507
- Transactions 1,943
About ALTUVIIIO
ALTUVIIIO is a biological associated with $1.9M in payments to 507 healthcare providers, recorded across 1,943 transactions in the CMS Open Payments database. The primary manufacturer is GENZYME CORPORATION.
Payment data is available from 2023 to 2024. In 2024, $1.2M was paid across 1,099 transactions to 351 doctors.
The most common payment nature for ALTUVIIIO is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.4M, 75.7% of total).
ALTUVIIIO is associated with 1 research study, including "Real-world Experience of Efanesoctocog Alfa Prophylaxis in US Patients with Hemophilia A" ($20,000).